HOXB2 promotes cisplatin resistance by upregulating lncRNA DANCR in ovarian cancer

• Main Authors: Xiao Li (Author), Zhen Zheng (Author), Wanzhen Zhou (Author), Huixian Huang (Author), Yang Zhou (Author), Qinyang Xu (Author), Xiaolu Zhu (Author), Yincheng Teng (Author)
• Format: Book
• Published: BMC, 2024-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Ovarian cancer (OV) is a highly fatal malignant disease that commonly manifests at an advanced stage. Drug resistance, particularly platinum resistance, is a leading cause of treatment failure because first-line systemic chemotherapy primarily relies on platinum-based regimens. By analyzing...